Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor...

Area of Science:

• Oncology
• Stem Cell Biology
• Cancer Research

Background:

• Mesenchymal stem cells (MSCs) are recruited into tumors, prompting extensive research into their role.
• Studies report conflicting results: MSCs can either promote or inhibit tumor development.
• Potential mechanisms include chemokine signaling, apoptosis modulation, vascular support, and immune modulation.

Purpose of the Study:

• To analyze methodological differences in studies investigating MSCs in tumors.
• To identify critical factors influencing MSCs' pro- or anti-tumorigenic effects.
• To understand the role of tumor stroma in carcinogenesis and inform MSC-based therapies.

Main Methods:

• Review of existing literature on exogenous mesenchymal stem cell administration in various tumor models.
• Comparative analysis of study methodologies, focusing on the timing of MSC introduction.
• Synthesis of reported mechanisms underlying MSC-mediated tumor promotion or inhibition.

Main Results:

• Contradictory findings in the literature regarding MSCs' impact on tumor growth.
• Identified the timing of MSC introduction as a potentially critical variable.
• Highlighted diverse mechanisms like chemokine signaling, apoptosis, vascular, and immune modulation.

Conclusions:

• The timing of mesenchymal stem cell introduction is a key determinant of their effect on tumor growth and metastasis.
• Further research is needed to elucidate conditions under which MSCs enhance or inhibit cancer.
• Understanding these dynamics is crucial for developing safe MSC-based therapies and advancing cancer stroma research.